Estrella Immunopharma ESLA
NASDAQ ESLA
$0.47 +0.01 (+1.78%)
At close: Oct 1, 2026 · 4:00 PM EDT

Estrella Immunopharma (ESLA) Receivables (2023)

Updated

Estrella Immunopharma's Receivables was $273,066 in Q1 2024, unchanged from the prior quarter.

Analysis

Estrella Immunopharma (ESLA) Receivables (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 19.05 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 13.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.68 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 5.06 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.13 Bn
10 Estrella Immunopharma 20.44 Mn 15.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 273,066.00
Jun 30, 2023 273,066.00
API Access

Estrella Immunopharma Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ESLA&period=max&api_key=YOUR_API_KEY